ArticleThe New England journal of medicine2003
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
Article in The New England journal of medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 2,952 papers, 12 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR
Study of the Phenotype of Overweight and Obese Adults
Preventing Breast Cancer Recurrence Through a Tailored Lifestyle Intervention.
Study of Impact of the Size of Gastric Sleeve o the Weight Loss in Patients Submitted to Bariatric Surgery. Evaluation of Changes in Gastric Motility and Endocrine-metabolic Function.
Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
Who cites it
2,952 citing papers in PubMed, 12 syntheses or guidelines pooled it.
- Pooled it
- Abnormal body weight and risk of gallbladder cancer: an updated meta-analysis incorporating recent evidence.BMC cancer · 2026Pooled it
- Body mass index and multiple myeloma: a systematic review and dose-response meta-analysis of prospective cohort studies.BMC cancer · 2026Pooled it
- Weight-reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta-analysis of randomized controlled trials.Diabetes, obesity & metabolism · 2026Pooled it
- GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials.Diabetes, obesity & metabolism · 2025 · on this mapPooled it
- Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications.BMC medicine · 2025Pooled it
- Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.The Cochrane database of systematic reviews · 2025Pooled it
- Does the use of staple line reinforcement during sleeve gastrectomy and Roux-en-Y gastric bypass affect ClinicalOutcomes?: Systematic review and Meta-analysis.Langenbeck's archives of surgery · 2025Pooled it
- Robotic single site versus robotic multiport hysterectomy in endometrial cancer: a systematic review and meta-analysis.BMC cancer · 2025Pooled it
- Effects of various exercise types on inflammatory response in individuals with overweight and obesity: a systematic review and network meta-analysis of randomized controlled trials.International journal of obesity (2005) · 2025Pooled it
- Pooled it
- European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer.Obesity facts · 2025Guideline
- Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.Nature communications · 2026Trial
- The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients.EMBO molecular medicine · 2026Trial
- A Clinical Early Evaluation of the Combined Use of Low-Intensity Focused Ultrasound and Radiofrequency for Female Abdominal Contouring.Journal of cosmetic dermatology · 2025Trial
- Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial.Scientific reports · 2025Trial
- Lipid Accumulation Promotes Tumorigenic Behaviour of Colorectal Cancer Cells.Journal of cellular and molecular medicine · 2026Article
- Cumulative obesity exposure and hepato-pancreato-biliary cancer risk following different weight-loss interventions: retrospective cohort study.Annals of medicine and surgery (2012) · 2026Article
- The Association Between Obesity Class and Cause-Specific Mortality by Age and Sex in US Adults.Clinical obesity · 2026Article
- Sex and Gender Perspective in Obesity and Gastric Cancer.The world journal of men's health · 2026Review
2,892 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe influence of excess body weight on the risk of death from cancer has not been fully characterized.
methodsIn a prospectively studied population of more than 900,000 U.S. adults (404,576 men and 495,477 women) who were free of cancer at enrollment in 1982, there were 57,145 deaths from cancer during 16 years of follow-up. We examined the relation in men and women between the body-mass index in 1982 and the risk of death from all cancers and from cancers at individual sites, while controlling for other risk factors in multivariate proportional-hazards models. We calculated the proportion of all deaths from cancer that was attributable to overweight and obesity in the U.S. population on the basis of risk estimates from the current study and national estimates of the prevalence of overweight and obesity in the U.S. adult population.
resultsThe heaviest members of this cohort (those with a body-mass index [the weight in kilograms divided by the square of the height in meters] of at least 40) had death rates from all cancers combined that were 52 percent higher (for men) and 62 percent higher (for women) than the rates in men and women of normal weight. For men, the relative risk of death was 1.52 (95 percent confidence interval, 1.13 to 2.05); for women, the relative risk was 1.62 (95 percent confidence interval, 1.40 to 1.87). In both men and women, body-mass index was also significantly associated with higher rates of death due to cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney; the same was true for death due to non-Hodgkin's lymphoma and multiple myeloma. Significant trends of increasing risk with higher body-mass-index values were observed for death from cancers of the stomach and prostate in men and for death from cancers of the breast, uterus, cervix, and ovary in women. On the basis of associations observed in this study, we estimate that current patterns of overweight and obesity in the United States could account for 14 percent of all deaths from cancer in men and 20 percent of those in women.
conclusionsIncreased body weight was associated with increased death rates for all cancers combined and for cancers at multiple specific sites.
Indexed as
Identifiers
12711737What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.